| アブストラクト | BACKGROUND: Bojungikki-tang (Buzhongyiqi decoction, Hochuekkito, BIT) has been used in East Asian medicine for conditions with fatigue, reduced appetite, and functional decline. In recent years, research on this preparation has expanded across diverse disease areas, yet its contemporary evidence landscape has not been systematically mapped. This scoping review aimed to characterize the scope, methodological features, outcome domains, botanical drug reporting, and safety reporting of studies published since 2015. METHODS: A comprehensive search of PubMed, Embase, CENTRAL, and OASIS was conducted to identify studies evaluating BIT. Eligible studies included randomized controlled trials non-randomized trials, observational studies, and case-based reports published from 2015 onward. Data were charted on study design, disease system, intervention characteristics, botanical composition, formulation reporting, outcome domains, and adverse-event reporting, and synthesized descriptively. RESULTS: Forty-seven studies involving 2,568 participants were included. RCTs accounted for 48.9%, while case-based studies comprised 27.7%. Oncology represented the largest disease cluster (27.7%), followed by urogenital (17.0%), neurologic (14.9%), and respiratory conditions (12.8%). BIT was used as monotherapy in 55.3% of studies and as an adjunct in 44.7%. Granule and decoction forms accounted for 89.4% of interventions. Outcomes assessed fatigue, appetite, quality of life, functional recovery, inflammatory and nutritional biomarkers, and treatment tolerance. Heterogeneity in formulation, comparators, outcomes, and safety reporting limited comparability. CONCLUSION: Recent studies suggest that BIT is investigated as a recovery-oriented intervention in conditions with immune-inflammatory stress and functional vulnerability. Greater standardization in botanical drug nomenclature, formulation definition, outcome frameworks, and harms reporting is needed for evidence-based botanical drug research. |
| 組織名 | KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon,;Republic of Korea.;Department of Internal Medicine, College of Korean Medicine, Daejeon University,;Daejeon, Republic of Korea. |